Haixiang Pharmaceutical: Semi-Annual Financial Report
Haixiang Pharmaceutical: Semi-annual Non-Operating Capital Occupancy and Other Related Capital Transactions Summary
Haixiang Pharmaceutical: Announcement on the Appointment of the Secretary of the Board
Haixiang Pharmaceutical: 2024 Semi-Annual Financial Report
Zhejiang Hisoar Pharmaceutical: Announcement on the Progress of Investment in Henlius by Participating Partnership Enterprises.
Zhejiang Hisoar Pharmaceutical: Haixiang Pharmaceutical's 2023 Annual Shareholders' Meeting Witnessed Legal Opinions
Zhejiang Hisoar Pharmaceutical: Announcement of Resolutions of the 2023 Annual General Meeting of Shareholders
Zhejiang Hisoar Pharmaceutical: Announcement on asset impairment preparations for the first quarter of 2024
Zhejiang Hisoar Pharmaceutical: Independent Directors' Annual Report Work System (Revised in April 2024)
Zhejiang Hisoar Pharmaceutical: Working system for special meetings of independent directors
Zhejiang Hisoar Pharmaceutical: Internal Control Self-Assessment Report
Zhejiang Hisoar Pharmaceutical: Announcement on the launch of the bill pool business
Zhejiang Hisoar Pharmaceutical: Announcement on preparation for impairment of assets accrued in 2023
Zhejiang Hisoar Pharmaceutical: Comparative table of amendments to the company's articles of association
Zhejiang Hisoar Pharmaceutical: Announcement on the launch of foreign exchange hedging business
Zhejiang Hisoar Pharmaceutical: Articles of Association (revised in April 2024)
Zhejiang Hisoar Pharmaceutical: Report on the performance of supervisory duties of accounting firms by the Audit Committee of the Board of Directors in 2023
Zhejiang Hisoar Pharmaceutical: Notice on Using Idle Own Funds for Cash Management
Zhejiang Hisoar Pharmaceutical: Notice on requesting the shareholders' meeting to authorize the board of directors to issue shares to specific targets through simple procedures
Zhejiang Hisoar Pharmaceutical: Board of Directors Rules of Procedure (Revised April 2024)
No Data
No Data